These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

784 related items for PubMed ID: 30664155

  • 21. Circular RNA ACVR2A promotes the progression of hepatocellular carcinoma through mir-511-5p targeting PI3K-Akt signaling pathway.
    Fei D, Wang F, Wang Y, Chen J, Chen S, Fan L, Yang L, Ren Q, Duangmano S, Du F, Liu H, Zhou J, Sheng J, Zhao Y, Wu X, Li M, Xiao Z, Zhang Z, Jiang X.
    Mol Cancer; 2024 Aug 06; 23(1):159. PubMed ID: 39107843
    [Abstract] [Full Text] [Related]

  • 22. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
    Yu M, Xue H, Wang Y, Shen Q, Jiang Q, Zhang X, Li K, Jia M, Jia J, Xu J, Tian Y.
    Int J Oncol; 2017 Mar 06; 50(3):975-983. PubMed ID: 28098858
    [Abstract] [Full Text] [Related]

  • 23. MiR-425-5p promotes invasion and metastasis of hepatocellular carcinoma cells through SCAI-mediated dysregulation of multiple signaling pathways.
    Fang F, Song T, Zhang T, Cui Y, Zhang G, Xiong Q.
    Oncotarget; 2017 May 09; 8(19):31745-31757. PubMed ID: 28423650
    [Abstract] [Full Text] [Related]

  • 24. Up-regulation of BRCA1-associated RING Domain 1 Promotes Hepatocellular Carcinoma Progression by Targeting Akt Signaling.
    Liao Y, Yuan S, Chen X, Zhu P, Li J, Qin L, Liao W.
    Sci Rep; 2017 Aug 09; 7(1):7649. PubMed ID: 28794477
    [Abstract] [Full Text] [Related]

  • 25. STK17B promotes carcinogenesis and metastasis via AKT/GSK-3β/Snail signaling in hepatocellular carcinoma.
    Lan Y, Han J, Wang Y, Wang J, Yang G, Li K, Song R, Zheng T, Liang Y, Pan S, Liu X, Zhu M, Liu Y, Meng F, Mohsin M, Cui Y, Zhang B, Subash S, Liu L.
    Cell Death Dis; 2018 Feb 14; 9(2):236. PubMed ID: 29445189
    [Abstract] [Full Text] [Related]

  • 26. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I, Pinyol R, Dauch D, Torrecilla S, Tovar V, Moeini A, Alsinet C, Portela A, Rodriguez-Carunchio L, Solé M, Lujambio A, Villanueva A, Thung S, Esteller M, Zender L, Llovet JM.
    Gastroenterology; 2016 Dec 14; 151(6):1192-1205. PubMed ID: 27614046
    [Abstract] [Full Text] [Related]

  • 27. Downregulation of miR-329 promotes cell invasion by regulating BRD4 and predicts poor prognosis in hepatocellular carcinoma.
    Zhou J, Li W, Guo J, Li G, Chen F, Zhou J.
    Tumour Biol; 2016 Mar 14; 37(3):3561-9. PubMed ID: 26456956
    [Abstract] [Full Text] [Related]

  • 28. miR-22 targets YWHAZ to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival.
    Chen M, Hu W, Xiong CL, Qu Z, Yin CQ, Wang YH, Luo CL, Guan Q, Yuan CH, Wang FB.
    Oncotarget; 2016 Dec 06; 7(49):80751-80764. PubMed ID: 27811373
    [Abstract] [Full Text] [Related]

  • 29. LncRNA DCST1-AS1 accelerates the proliferation, metastasis and autophagy of hepatocellular carcinoma cell by AKT/mTOR signaling pathways.
    Li J, Zhai DS, Huang Q, Chen HL, Zhang Z, Tan QF.
    Eur Rev Med Pharmacol Sci; 2019 Jul 06; 23(14):6091-6104. PubMed ID: 31364110
    [Abstract] [Full Text] [Related]

  • 30. Upregulation of lncRNA FER1L4 suppresses the proliferation and migration of the hepatocellular carcinoma via regulating PI3K/AKT signal pathway.
    Wang X, Dong K, Jin Q, Ma Y, Yin S, Wang S.
    J Cell Biochem; 2019 Apr 06; 120(4):6781-6788. PubMed ID: 30382631
    [Abstract] [Full Text] [Related]

  • 31. Inhibition of CTRP6 prevented survival and migration in hepatocellular carcinoma through inactivating the AKT signaling pathway.
    Wan X, Zheng C, Dong L.
    J Cell Biochem; 2019 Oct 06; 120(10):17059-17066. PubMed ID: 31111552
    [Abstract] [Full Text] [Related]

  • 32. DDX17 promotes hepatocellular carcinoma progression via inhibiting Klf4 transcriptional activity.
    Xue Y, Jia X, Li C, Zhang K, Li L, Wu J, Yuan J, Li Q.
    Cell Death Dis; 2019 Oct 25; 10(11):814. PubMed ID: 31653828
    [Abstract] [Full Text] [Related]

  • 33. KLF4 Suppresses the Progression of Hepatocellular Carcinoma by Reducing Tumor ATP Synthesis through Targeting the Mir-206/RICTOR Axis.
    Wang Y, Zuo D, Huang Z, Qiu Y, Wu Z, Liu S, Zeng Y, Qiu Z, He W, Li B, Yuan Y, Niu Y, Qiu J.
    Int J Mol Sci; 2024 Jun 28; 25(13):. PubMed ID: 39000273
    [Abstract] [Full Text] [Related]

  • 34. Downregulation of LncRNAH19 and MiR-675 promotes migration and invasion of human hepatocellular carcinoma cells through AKT/GSK-3β/Cdc25A signaling pathway.
    Lv J, Ma L, Chen XL, Huang XH, Wang Q.
    J Huazhong Univ Sci Technolog Med Sci; 2014 Jun 28; 34(3):363-369. PubMed ID: 24939300
    [Abstract] [Full Text] [Related]

  • 35. MicroRNA‑340 inhibits tumor cell proliferation, migration and invasion, and induces apoptosis in hepatocellular carcinoma.
    Wang Z, Song D, Huang P.
    Mol Med Rep; 2017 Nov 28; 16(5):7649-7656. PubMed ID: 28944918
    [Abstract] [Full Text] [Related]

  • 36. LINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt/mTOR Signaling Pathway.
    Zheng YL, Li L, Jia YX, Zhang BZ, Li JC, Zhu YH, Li MQ, He JZ, Zeng TT, Ban XJ, Yuan YF, Li Y, Guan XY.
    Theranostics; 2019 Nov 28; 9(3):796-810. PubMed ID: 30809309
    [Abstract] [Full Text] [Related]

  • 37. CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling.
    Zhou SL, Zhou ZJ, Hu ZQ, Li X, Huang XW, Wang Z, Fan J, Dai Z, Zhou J.
    Cancer Lett; 2015 Mar 28; 358(2):124-135. PubMed ID: 25462858
    [Abstract] [Full Text] [Related]

  • 38. LncRNA FOXD3-AS1 Mediates AKT Pathway to Promote Growth and Invasion in Hepatocellular Carcinoma Through Regulating RICTOR.
    Liu C, Zhang M, Zhao J, Zhu X, Zhu L, Yan M, Zhang X, Zhang R.
    Cancer Biother Radiopharm; 2020 May 28; 35(4):292-300. PubMed ID: 32191537
    [Abstract] [Full Text] [Related]

  • 39. Unveiling the role of the KLF4/Lnc18q22.2/ULBP3 axis in the tumorigenesis and immune escape of hepatocellular carcinoma under hypoxic condition.
    Wei L, He P, Tan Z, Zhao L, Lin C, Wei Z.
    J Cell Mol Med; 2024 May 28; 28(10):e18411. PubMed ID: 38780505
    [Abstract] [Full Text] [Related]

  • 40. ACK1 promotes hepatocellular carcinoma progression via downregulating WWOX and activating AKT signaling.
    Xie B, Zen Q, Wang X, He X, Xie Y, Zhang Z, Li H.
    Int J Oncol; 2015 May 28; 46(5):2057-66. PubMed ID: 25738261
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 40.